Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 3Wound Infection 1Urinary Tract Infections 1Stomatitis 1Skin Neoplasms 1Sepsis 1Prostatic Neoplasms 1Pleural Effusion 1Head and Neck Neoplasms 1Fever 1Esophageal Neoplasms 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 3ibrutinib 2Rituximab 2Imatinib Mesylate 2ziconotide 1ruxolitinib 1ponatinib 1ofatumumab 1nilotinib 1lonafarnib 1fludarabine 1bosutinib 1Surveys and Questionnaires 1Specimen Handling 1SLC25A33 protein, human 1Povidone-Iodine 1Physical Therapy Modalities 1Pentostatin 1Lenalidomide 1Dasatinib 1Cyclophosphamide 1Bone Marrow Transplantation 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bronchiolitis Obliterans Syndrome × Povidone-Iodine × Clear all
NCT02975921 2019-01-11

Betadine Pleurodesis Via Tunneled Pleural Catheters

Yale University

Phase 4 Withdrawn
Thoracic

Bronchiolitis Obliterans Syndrome, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡